Kathleen Goin
CIK: 0001912570
Transaction Breakdown
High conviction signal
Position reduction
Derivative conversions
Compensation grants
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
PALVELLA THERAPEUTICS, INC.
Discretionary Trading P&L
Holdings
Transaction History (64 total)
- Oct 21, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.2K shares at avg. $7.14$15K - Oct 21, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.1K shares at avg. $9.08$20K - Oct 21, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct1.7K shares at avg. $125.16$208K - Oct 21, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct607 shares at avg. $126.19$77K - Oct 21, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct2K shares at avg. $123.62$253K - Sep 16, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct1.7K shares at avg. $153.24$253K - Sep 16, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.2K shares at avg. $7.14$15K - Sep 16, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.1K shares at avg. $9.08$20K - Sep 16, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct989 shares at avg. $152.36$151K - Sep 16, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct1.7K shares at avg. $151.16$251K - Aug 19, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct1.5K shares at avg. $151.39$227K - Aug 19, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct302 shares at avg. $156.77$47K - Aug 19, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct2K shares at avg. $151.80$303K - Aug 19, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct400 shares at avg. $153.00$61K - Aug 19, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.1K shares at avg. $9.08$20K - Aug 19, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct102 shares at avg. $155.59$16K - Aug 19, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.2K shares at avg. $7.14$15K - Jul 15, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.2K shares at avg. $7.14$15K - Jul 15, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.1K shares at avg. $9.08$20K - Jul 15, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct1.9K shares at avg. $150.25$287K - Jul 15, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct522 shares at avg. $147.14$77K - Jul 15, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct840 shares at avg. $148.40$125K - Jul 15, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct1K shares at avg. $149.27$154K - Jun 17, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Exercise(M)Direct2.1K shares at avg. $9.08$20K - Jun 17, 2026PVLA
PALVELLA THERAPEUTICS, INC.
Sale(S)Direct25 shares at avg. $112.23$3K
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Oct 21, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,165 | $7.14 | $15,458 | Direct |
| Oct 21, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,148 | $9.08 | $19,504 | Direct |
| Oct 21, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 1,663 | $125.16 | $208,149 | Direct |
| Oct 21, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 607 | $126.19 | $76,600 | Direct |
| Oct 21, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 2,043 | $123.62 | $252,559 | Direct |
| Sep 16, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 1,654 | $153.24 | $253,465 | Direct |
| Sep 16, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,154 | $7.14 | $15,380 | Direct |
| Sep 16, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,148 | $9.08 | $19,504 | Direct |
| Sep 16, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 989 | $152.36 | $150,686 | Direct |
| Sep 16, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 1,659 | $151.16 | $250,773 | Direct |
| Aug 19, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 1,500 | $151.39 | $227,085 | Direct |
| Aug 19, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 302 | $156.77 | $47,345 | Direct |
| Aug 19, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 1,998 | $151.80 | $303,292 | Direct |
| Aug 19, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 400 | $153.00 | $61,199 | Direct |
| Aug 19, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,148 | $9.08 | $19,504 | Direct |
| Aug 19, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 102 | $155.59 | $15,870 | Direct |
| Aug 19, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,154 | $7.14 | $15,380 | Direct |
| Jul 15, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,154 | $7.14 | $15,380 | Direct |
| Jul 15, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,148 | $9.08 | $19,504 | Direct |
| Jul 15, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 1,911 | $150.25 | $287,133 | Direct |
| Jul 15, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 522 | $147.14 | $76,805 | Direct |
| Jul 15, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 840 | $148.40 | $124,658 | Direct |
| Jul 15, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 1,029 | $149.27 | $153,595 | Direct |
| Jun 17, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Exercise(M) | 2,148 | $9.08 | $19,504 | Direct |
| Jun 17, 2026 | PVLA PALVELLA THERAPEUTICS, INC. | Sale(S) | 25 | $112.23 | $2,806 | Direct |
1-25 of 64 transactions
About Goin Kathleen
Goin Kathleen (SEC CIK 0001912570) files insider reports with the SEC as Chief Operating Officer of PALVELLA THERAPEUTICS, INC. (PVLA).
Signal8 holds 16 ownership filings by Goin Kathleen (1 Form 3, 15 Form 4), filed between Dec 16, 2024 and Oct 23, 2026. Those filings report 64 transactions, from Dec 13, 2024 to Oct 21, 2026. Signal8's Form 4 history starts in Sep 2024.
The business address on Goin Kathleen's filings is in WAYNE, PA.
Recent filings by Goin Kathleen
- Oct 21, 2026: Option exercises of PVLA shares (2 lines, Form 4, code M).
- Oct 21, 2026: Open-market sales of PVLA shares (3 lines, Form 4, code S).
- Sep 16, 2026: Open-market sale of PVLA shares (Form 4, code S).
- Sep 16, 2026: Option exercises of PVLA shares (2 lines, Form 4, code M).
- Sep 16, 2026: Open-market sales of PVLA shares (2 lines, Form 4, code S).
Other insiders filing for PALVELLA THERAPEUTICS, INC. (PVLA)
- JENKINS GEORGE M, Director
- KIRITSY CHRISTOPHER P, Director
- Pauls Matthew, Director
- Korenberg Matthew E, CFO, Treasurer
- HERON ELAINE J, Director
- Doux John, Director